SERUM NITRATE LEVELS IN ULCERATIVE-COLITIS AND CROHNS-DISEASE

被引:74
作者
POOL, MO
BOUMA, G
VISSER, JJ
KOLKMAN, JJ
TRAN, DD
MEUWISSEN, SGM
PENA, AS
机构
[1] FREE UNIV AMSTERDAM HOSP, DEPT GASTROENTEROL, 1081 HV AMSTERDAM, NETHERLANDS
[2] FREE UNIV AMSTERDAM HOSP, DEPT CLIN CHEM, 1081 HV AMSTERDAM, NETHERLANDS
[3] FREE UNIV AMSTERDAM HOSP, DEPT SURG, 1081 HV AMSTERDAM, NETHERLANDS
关键词
ACTIVITY INDEX; CROHNS DISEASE; DIAGNOSTIC MARKER; INFLAMMATORY BOWEL DISEASE; NITRIC OXIDE; SERUM NITRATE CONCENTRATION; ULCERATIVE COLITIS;
D O I
10.3109/00365529509096328
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background: Nitric oxide is an important mediator in inflammatory and autoimmune-mediated tissue destruction and may be of pathophysiologic importance in inflammatory bowel disease. We studied whether serum levels of nitrate, the stable end-product of nitric oxide, are increased in active Crohn's disease or ulcerative colitis, in comparison with quiescent disease and healthy controls. The setting was the gastroenterology unit of the Free University Hospital, Amsterdam. Methods: In 146 patients-75 with ulcerative colitis and 71 with Crohn's disease-and 33 controls serum nitrate was measured by the Griess reaction after enzymatic conversion of nitrate to nitrite with nitrate reductase. Results: Median serum nitrate concentrations did not differ statistically significantly between ulcerative colitis (median, 34.2 mu mol/l; range, 15.6-229.4 mu mol/l), Crohn's disease (median 32.3 mu mol/l; range 13.2-143.2 mu mol/l), and healthy controls (median, 28.7 mu mol/l; range, 13.0-108.4 mu mol/l). However, when active ulcerative colitis patients (median, 44 mu mol/l; range, 29.1-229.4 mu mol/l were compared with inactive ulcerative colitis patients (median, 31.2 mu mol/l; range, 15.6-59.7 mu mol/l), a significant difference in nitrate concentration was found (p < 0.0001). A significant positive correlation was found between serum nitrate levels in ulcerative colitis and erythrocyte sedimentation rate (ESR) (r = 0.30, p = 0.01), leucocyte count (r = 0.27, p = 0.02), and thrombocyte count (r = 0.24, p = 0.04). Comparing active Crohn's disease patients (median, 37.5 mu mol/l; range, 13.2-143.2 mu mol/l) with inactive Crohn's disease patients (median, 31.3 mu mol/l; range, 14.5-92.3 mu mol/l) also showed a significant difference in serum nitrate concentration (p < 0.009). Serum nitrate levels correlated with the ESR (r = 0.26, p = 0.028) and serum albumin (r = -0.38, p = 0.004) as well. Conclusion: Nitric oxide production is increased in both active ulcerative colitis and Crohn's disease and may be implicated in the pathogenesis of inflammatory bowel disease.
引用
收藏
页码:784 / 788
页数:5
相关论文
共 35 条
[31]  
Miller M.J.S., Sadowska H., Chotinaruernol S., Kakkis J.L., Clark D.A., Amelioration of chronic ileitis by nitric oxide synthase inhibition, J Pharmacol Exp Ther, 264, pp. 11-16, (1993)
[32]  
Neilly P.J.D., Anderson N.H., Kirk S.J., Gardiner KR, Halliday MI. Rowlands BJ. L-Arginine exacerbates the inflammatory response in experimental IBD, Gut, 34, (1993)
[33]  
Bratt J., Gyllenhammer H., Palmblad J., The role of nitric oxide for human endothelial cytolysis induced by lipoxin A4 activated polymorphonuclear neutrophils in vitro, Clin Res, 42, (1994)
[34]  
Miller M.J., Chotinaruemol S., Sadowska-Krowicka H., Hakkis J.J., Munski U.R., Zhang X., Et al., Nitric oxide: the Jekyll and Hyde of gut inflammation, Agents Actions, 39, pp. 180-182, (1993)
[35]  
Thompson J.A., Sadowska-Krowicka H., Rossi J., Clark D.A., Miller M.J.S., Inducible nitric oxide synthase gene expression in guinea pig ileitis: a model of IBD prevented by aminoguanidine, Gastroenterology, 106, (1994)